Loading...
MET/HGF pathway activation as a paradigm of resistance to targeted therapies
Resistance to targeted therapeutics is a key issue limiting the long-term utility of these medications in the management of molecularly selected subsets of cancer patients, including patients with non-small cell lung cancer harboring oncogenic alterations affecting EGFR, ALK and other genes. Bypass...
Na minha lista:
| Udgivet i: | Ann Transl Med |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AME Publishing Company
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5253284/ https://ncbi.nlm.nih.gov/pubmed/28164089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.12.09 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|